Erasca (ERAS) executive compensation, 2026 proxy

Jonathan E. Lim, M.D., Chairman, Chief Executive Officer, and Co-Founder, was paid $4.3M in fiscal 2025, up 10% from $3.9M the year before.

Filed
April 28, 2026
Annual meeting
June 26, 2026
Pay year
fiscal 2025
Named executives
3
CEO total pay
$4.3M+10% vs prior year
CEO Target Bonus %
60%Expressed as percentage of annual base salary
2025 Bonus Payout %
120%Approved payout percentage of target levels
CEO 2025 Salary
$670,400Effective January 1, 2025

How M.D. was paid

$4.3M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary16%Option awards73%Non-equity incentive11%All other compensation0%

Named executive officers

ExecutiveTotal
Jonathan E. Lim, M.D.Chairman, Chief Executive Officer, and Co-Founder$4,298,838
David M. Chacko, M.D.Chief Financial Officer and Chief Business Officer$1,778,496
Shannon R. Morris, M.D., Ph.D.Chief Medical Officer$1,750,898

What changed and why

  • $4.3MJonathan E. Lim received total compensation of $4,298,838 for fiscal year 2025.
  • 120%Annual performance bonuses for 2025 were approved at 120% of target levels.
  • $670KJonathan E. Lim's base salary increased to $670,400 effective January 1, 2025.
  • $3.1MOption awards for Jonathan E. Lim were valued at $3,135,250 in 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.